Rosuvastatin is contraindicated in patients with active liver disease, including unexplained, persistent elevations of hepatic aminotransferases. It is also contraindicated in pregnant patients as suppression of cholesterol biosynthesis could cause fetal harm.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
